Rayner Announces Three Key Appointments to Management Board

Rayner has made three key additions to its management board to foster continued growth and development within the organization.

James Crutchlow has been appointed as Chief Commercial Officer, Rob Nadler as Chief Growth Officer, and Chris Willis as Chief Marketing Officer, effective immediately.

Rayner's CEO, Tim Clover, emphasized the importance of these changes, stating, "This important change will help us to maintain our track record of innovation and ensure the company remains agile and focused on ophthalmologists."

James Crutchlow, who joined Rayner in 2008, has held various leadership positions within the company, including Vice President Europe. With extensive experience in commercial execution and market expansion, Crutchlow will now lead a unified global commercial group to drive continued growth.

Dr. Rob Nadler, leveraging his 18 years of experience in investment banking and ophthalmology, steps into the role of Chief Growth Officer. Having previously led corporate development at Rayner, Nadler will focus on research and development, corporate expansion, and mergers and acquisitions.

Chris Willis, with over 20 years of experience in the ophthalmology industry and a successful tenure as Vice President Marketing, transitions into the role of Chief Marketing Officer. This move reflects Rayner's recognition of the critical role marketing, eye science, and digital healthcare play in the company's future growth trajectory.